IPSC · Categories · Form 4

IPSC - SEC Form 4 insider transactions

Century Therapeutics Inc. (IPSC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IPSC

• 20d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.84% to 3,679,786 units (SEC Form 4) to satisfy withholding tax

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 33d
  SVP Finance & Operations Carr Douglas sold $618 worth of shares (264 units at $2.34), decreasing direct ownership by 0.05% to 506,997 units (SEC Form 4) (for withholding tax)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 59d
  SEC Form 4 filed by Murphy Martin Patrick

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 66d
  SEC Form 4 filed by Cowan Chad

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 84d
  SVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 84d
  Officer Russotti Gregory sold $25,684 worth of shares (10,076 units at $2.55), decreasing direct ownership by 2% to 515,427 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 87d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 55,397 shares, decreasing direct ownership by 1% to 3,710,958 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 87d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,431 shares, decreasing direct ownership by 0.12% to 1,177,045 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 89d
  SEC Form 4 filed by Century Therapeutics Inc.

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 89d
  SVP Finance & Operations Carr Douglas sold $626 worth of shares (247 units at $2.54), decreasing direct ownership by 0.05% to 514,304 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 90d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,766,355 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 110d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.82% to 3,766,818 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 123d
  SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 124d
  President and CEO Pfeiffenberger Brent was granted 475,000 shares, increasing direct ownership by 14% to 3,797,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 124d
  Officer Russotti Gregory was granted 135,000 shares, increasing direct ownership by 35% to 525,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 124d
  Chief Scientific Officer Cowan Chad was granted 135,000 shares, increasing direct ownership by 13% to 1,178,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 124d
  SVP Finance & Operations Carr Douglas was granted 110,000 shares, increasing direct ownership by 27% to 514,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 153d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,611 shares, decreasing direct ownership by 0.15% to 1,043,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 178d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,270,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 179d
  SEC Form 4 filed by Director Lee Han Myung

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 180d
  SVP Finance & Operations Carr Douglas sold $137 worth of shares (257 units at $0.53), decreasing direct ownership by 0.06% to 404,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 180d
  Officer Russotti Gregory sold $280 worth of shares (526 units at $0.53), decreasing direct ownership by 0.13% to 390,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 196d
  Chief Scientific Officer Cowan Chad sold $2,736 worth of shares (5,462 units at $0.50), decreasing direct ownership by 0.55% to 987,027 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 201d
  President and CEO Pfeiffenberger Brent sold $14,735 worth of shares (32,456 units at $0.45), decreasing direct ownership by 0.99% to 3,236,453 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 215d
  SVP Finance & Operations Carr Douglas sold $171 worth of shares (292 units at $0.59), decreasing direct ownership by 0.07% to 405,131 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 259d
  Chief Scientific Officer Cowan Chad was granted 762,543 shares, increasing direct ownership by 332% to 992,489 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 271d
  SVP Finance & Operations Carr Douglas sold $132 worth of shares (263 units at $0.50), decreasing direct ownership by 0.06% to 405,423 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 271d
  President and CEO Pfeiffenberger Brent sold $244 worth of shares (488 units at $0.50), decreasing direct ownership by 0.01% to 3,268,909 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 271d
  Officer Russotti Gregory sold $270 worth of shares (539 units at $0.50), decreasing direct ownership by 0.14% to 391,508 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 294d
  President and CEO Pfeiffenberger Brent was granted 1,587,614 shares, increasing direct ownership by 94% to 3,269,397 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 306d
  SVP Finance & Operations Carr Douglas sold $158 worth of shares (296 units at $0.53), decreasing direct ownership by 0.07% to 405,686 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Blackwell Kimberly

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Jimenez Joseph

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Riva Alessandro

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Carlo Rizzuto

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Quimi Daphne

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Butitta Cynthia M

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 357d
  SEC Form 4 filed by Director Walbert Timothy P

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 362d
  SVP Finance & Operations Carr Douglas sold $3,050 worth of shares (4,904 units at $0.62), decreasing direct ownership by 1% to 405,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 362d
  Chief Operations Officer Farid Adrienne sold $343 worth of shares (552 units at $0.62), decreasing direct ownership by 0.22% to 250,141 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 362d
  President and CEO Pfeiffenberger Brent sold $295 worth of shares (475 units at $0.62), decreasing direct ownership by 0.03% to 1,681,783 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 362d
  Officer Russotti Gregory sold $327 worth of shares (526 units at $0.62), decreasing direct ownership by 0.13% to 392,047 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 384d
  President and CEO Pfeiffenberger Brent sold $16,135 worth of shares (29,552 units at $0.55), decreasing direct ownership by 2% to 1,682,258 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 397d
  Chief Operations Officer Farid Adrienne sold $563 worth of shares (1,024 units at $0.55), decreasing direct ownership by 0.41% to 250,693 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 397d
  SVP Finance & Operations Carr Douglas sold $162 worth of shares (295 units at $0.55), decreasing direct ownership by 0.07% to 410,886 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  Chief Finanical Officer Conn Morgan was granted 19,500 shares, increasing direct ownership by 32% to 79,648 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  Chief Scientific Officer Cowan Chad was granted 19,500 shares, increasing direct ownership by 9% to 230,306 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  President and CEO Pfeiffenberger Brent was granted 521,500 shares and sold $1,375 worth of shares (2,235 units at $0.61), increasing direct ownership by 44% to 1,711,810 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  Officer Russotti Gregory sold $1,451 worth of shares (2,360 units at $0.61) and was granted 120,000 shares, increasing direct ownership by 43% to 392,573 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  Chief Operations Officer Farid Adrienne sold $1,451 worth of shares (2,359 units at $0.61) and was granted 120,000 shares, increasing direct ownership by 88% to 251,717 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 453d
  SVP Finance & Operations Carr Douglas sold $763 worth of shares (1,240 units at $0.61) and was granted 95,625 shares, increasing direct ownership by 30% to 411,181 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 473d
  President and CEO Pfeiffenberger Brent sold $27,179 worth of shares (34,712 units at $0.78), decreasing direct ownership by 3% to 1,192,545 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 488d
  Chief Operations Officer Farid Adrienne sold $822 worth of shares (1,054 units at $0.78), decreasing direct ownership by 0.78% to 134,076 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 488d
  SVP Finance & Operations Carr Douglas sold $274 worth of shares (351 units at $0.78), decreasing direct ownership by 0.11% to 316,796 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 549d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 243,447 shares, decreasing direct ownership by 17% to 1,227,257 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 580d
  Chief Operations Officer Farid Adrienne sold $1,267 worth of shares (1,033 units at $1.23), decreasing direct ownership by 0.76% to 135,130 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 580d
  SVP Finance & Operations Carr Douglas covered exercise/tax liability with 16,611 shares and sold $347 worth of shares (283 units at $1.23), decreasing direct ownership by 5% to 317,147 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 600d
  Chief Finanical Officer Conn Morgan was granted 60,148 shares (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 613d
  Chief Scientific Officer Cowan Chad was granted 74,376 shares, increasing direct ownership by 55% to 210,806 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 670d
  Chief Operations Officer Farid Adrienne sold $1,960 worth of shares (1,073 units at $1.83), decreasing direct ownership by 0.78% to 136,163 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)

Other IPSC categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends